and 48% (n ¼ 24) of controls had the four repeats. Thus, clinical subjects were significantly more likely than controls to carry the four-repeat high transcription allele (w 2 ¼ 6.000, d.f. ¼ 1, P ¼ 0.014). Linkage disequilibrium tests between the VNTR and MAOA Exon 8 suggested that the two were moderately linked (D 0 ¼ À0.61; w 2 ¼ 1.19, d.f. ¼ 1, Po0.0001). However, there were no significant differences between the cases and controls in the frequency of the haplotypes.
A total of 80% of subjects in our ethnically matched clinical and control samples were Caucasian, while the remaining 20% were African-American. The MAOA allele frequencies in our Caucasian controls were not significantly different from the Caucasian frequencies reported by Sabol et al. 6 Our African American sample was too small to evaluate the differences.
Persistently and pervasively aggressive children were significantly more likely to carry the four-repeat high transcription allele than adult normal controls. This finding is consistent with Manuck's report on dispositional aggressiveness among adults. 2 Since the four-repeat is also preferentially transmitted to children with ADHD, 7 high MAOA transcription may be associated with persistent and pervasive disruptive childhood disorders more broadly defined. Increased transcription of the MAOA gene may influence early behavior by means of its consistent degradative impact on 5-HT and, possibly, NE and DA.
We note that Caspi et al 1 have reported that the low transcription allele of the MAOA VNTR is associated with adolescent conduct disorder (CD) and adult conviction for a violent crime among subjects with a history of maltreatment. We suggest several explanations for the discrepancy between our finding and theirs. First, it is possible that a nearby marker, and not the VNTR itself, is associated with the aggressive phenotype. Second, CD/adult crime and persistent childhood aggression may represent qualitatively different psychiatric phenomena, and consequently be associated with different genotypes. Although existing evidence points to continuities between COA and adolescent CD, many adolescents with CD do not have a long-term history of COA. Third, the Caspi finding emerged on the basis of an interaction between childhood maltreatment and the VNTR polymorphism. There is no evidence that children in our study were maltreated, and our finding may reflect an interaction with yet another genetic or environmental risk factor.
A limitation of our study is that the control group consisted of adults who reported retrospectively on their psychiatric history. It is possible that some control subjects exhibited aggressive behavior as children. However, since the clinical group had a minimum 2-year history of extreme (above the 90th percentile) aggressive behavior, it is unlikely that many adult controls exhibited this phenotype. Contamination of the control sample would minimize, not amplify, differences in allele frequency between clinical subjects and controls.
Chronically and pervasively aggressive children were significantly more likely to carry the four-repeat allele than adult normal controls. Summarizing across studies, it appears that the promoter region of the MAOA gene is associated with high aggression; however, it is unclear whether the VNTR itself or another nearby DNA variant is functionally responsible for the manifestation of aggression. Further investigation of the relation between the high MAOA transcription allele and persistent pervasive childhood-onset aggressive behavior is warranted. SIR -The addictions are complex diseases whose onset, persistence, and treatment are influenced by interactions between genetic, environmental, and pharmacological factors. 1 A study of 3372 twin pairs found that genetic, shared environmental, and nonshared environmental factors similarly influence the development of drug abuse and dependence. 2 The authors also found that 54% of the total and 38% of the unique variance in heroin abuse were attributable to genetic factors.
Mu-opioid receptor (OPRM1) gene polymorphisms are logical candidates for association studies in the addictive diseases. 3 The endogenous opioid system is central to the function and modulation of physiological systems affected by all drugs of abuse. 1 Quantitative trait locus studies and studies in OPRM1 knockout mice have confirmed the importance of this receptor to the rewarding effects of opiates and other drugs of abuse. [4] [5] [6] Two single-nucleotide polymorphisms (SNP) within the coding region (C17 T and A118G) of exon 1 of the OPRM1 gene encode amino-acid substitutions and have a high frequency in specific populations (range 2-48%). 3 Using in vitro cellular assays, we demonstrated that receptors encoded by the variant 118G allele of the A118G SNP have increased affinity for the endogenous mu-opioid ligand b-endorphin and increased activation of G protein-activated inwardly rectifying potassium channels following binding by b-endorphin. 7 The influence of this SNP on human physiology has also been demonstrated in two studies of healthy volunteers showing increased hypothalamic-pituitary-adrenal axis response to the opiate antagonist naloxone in subjects with an 118G allele compared to subjects with only 118A alleles. 8, 9 Another report also provides evidence that alcoholdependent subjects with an 118G allele return to heavy drinking later following treatment with the opiate antagonist naltrexone than do similarly treated alcoholics with the prototype receptor. 10 Owing to its demonstrated effect on cellular and human physiology, we again selected the A118G SNP for analysis in the current study. To reduce the potential effect of population admixture, we studied a population of primarily Swedish subjects from Huddinge-Stockholm, Sweden.
The participating institutions' human subjects ethics committees approved this study and all subjects provided written informed consent for genetic studies. In all, 170 normal volunteer subjects with a mean age of 36.5 years (SD78.3; 52% female) were recruited as population-based controls for a large general health study. Normal volunteer subjects with a lifetime diagnosis of any psychotic disorder, drug or alcohol abuse, or drug or alcohol dependence were excluded from this study. In all, 139 heroinaddicted subjects with a mean age of 45.6 years (SD715.9; 23% female) were recruited from a chemical dependency unit where they were seeking detoxification for heroin dependence. DSM-IV criteria for opiate dependence was determined through a physician interview and the DSM-IV Checklist. Some opiate-dependent subjects met criteria for other axis I diagnoses such as alcohol abuse or dependence, and also major depression, anxiety, and panic disorder although the latter three diagnoses were generally secondary to substance dependence and not primary diagnoses.
Genomic DNA was isolated from peripheral blood lymphocytes and amplified by PCR using primers designed to amplify the complete coding region of exon 1 of the OPRM1 gene. PCR products were purified and sequenced at The Rockefeller University DNA Sequencing Center. Genotypes were determined by two independent assessors (GB and KSL) who were blind to the diagnostic data.
The overall frequency of each genotype and allele was determined. The odds ratio (OR) was calculated Table 1 Genotype and allelic distribution of the A118G polymorphism in all control and opiate-dependent subjects; subset data from Swedish subjects with two Swedish parents
All subjects
Swedish with both parents Swedish To minimize concerns about population admixture, a subgroup analysis was performed in subjects identifying themselves and both parents as Swedish (67 heroin addicts and 120 controls). Although the sample size is smaller, the association between the 118G allele and heroin addiction persists (OR ¼ 2.72, w In this subgroup, the attributable risk due to genotypes with a G allele was 21.0 (95% CI 6.0-34.0%) ( Table 1) .
The results of our study provide evidence for association of the 118G allele in exon 1 of the OPRM1 gene contributing to increased OR for heroin addiction. The results also indicate that up to 21.0% of the attributable risk of heroin addiction is mediated by the 118G allele.
To date, studies in Caucasian populations have not found an association between opiate dependence and the A118G SNP. A possible explanation for these results may lie in the diversity of allele frequency across and within populations. This study was in subjects from central Sweden, a group with little admixture over the past several hundred years. In this report, we controlled for allelic frequency differences in populations by performing a subgroup analysis of Swedish subjects with two Swedish parents. In conclusion, the current study found a significant association between the 118G allele of this functional polymorphism in the OPRM1 gene and heroin addiction in central Sweden. The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA;
